Global Newborn Screening Market Size, Share, And Analysis And Forecast 2023 – 2032
The global newborn screening market is expected to reach USD 1.52 billion by 2032, at a CAGR of 7.2% during the forecast period 2023 to 2032.
Newborn screening is a vital public health initiative aimed at identifying genetic, metabolic, and congenital disorders in infants shortly after birth, allowing for early intervention and treatment. Typically conducted within the first few days of life, this screening involves a simple blood test, often referred to as the "heel prick," to collect a small sample of a newborn's blood.